These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32580296)

  • 1. Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations.
    Zurl C; Waller M; Schwameis F; Muhr T; Bauer N; Zollner-Schwetz I; Valentin T; Meinitzer A; Ullrich E; Wunsch S; Hoenigl M; Grinschgl Y; Prattes J; Oulhaj A; Krause R
    J Fungi (Basel); 2020 Jun; 6(2):. PubMed ID: 32580296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical research advances of isavuconazole in the treatment of invasive fungal diseases.
    Zhang T; Shen Y; Feng S
    Front Cell Infect Microbiol; 2022; 12():1049959. PubMed ID: 36530445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased isavuconazole trough concentrations in the treatment of invasive aspergillosis in an adult patient receiving extracorporeal membrane oxygenation support.
    Miller M; Kludjian G; Mohrien K; Morita K
    Am J Health Syst Pharm; 2022 Jul; 79(15):1245-1249. PubMed ID: 35377411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability of Isavuconazole Trough Concentrations during Longitudinal Therapeutic Drug Monitoring.
    Bolcato L; Thiebaut-Bertrand A; Stanke-Labesque F; Gautier-Veyret E
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation.
    Kriegl L; Hatzl S; Zurl C; Reisinger AC; Schilcher G; Eller P; Gringschl Y; Muhr T; Meinitzer A; Prattes J; Hoenigl M; Krause R
    J Antimicrob Chemother; 2022 Aug; 77(9):2500-2505. PubMed ID: 35726095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isavuconazole for COVID-19-Associated Invasive Mold Infections.
    Ullah N; Sepulcri C; Mikulska M
    J Fungi (Basel); 2022 Jun; 8(7):. PubMed ID: 35887431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isavuconazole Treatment for Invasive Fungal Infections in Pediatric Patients.
    Zimmermann P; Brethon B; Roupret-Serzec J; Caseris M; Goldwirt L; Baruchel A; de Tersant M
    Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetics of Isavuconazole in Critical Care Patients with COVID-19-Associated Pulmonary Aspergillosis and Monte Carlo Simulations of High Off-Label Doses.
    Perez L; Corne P; Pasquier G; Konecki C; Sadek M; Le Bihan C; Klouche K; Mathieu O; Reynes J; Cazaubon Y
    J Fungi (Basel); 2023 Feb; 9(2):. PubMed ID: 36836325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.
    Marty FM; Ostrosky-Zeichner L; Cornely OA; Mullane KM; Perfect JR; Thompson GR; Alangaden GJ; Brown JM; Fredricks DN; Heinz WJ; Herbrecht R; Klimko N; Klyasova G; Maertens JA; Melinkeri SR; Oren I; Pappas PG; Ráčil Z; Rahav G; Santos R; Schwartz S; Vehreschild JJ; Young JH; Chetchotisakd P; Jaruratanasirikul S; Kanj SS; Engelhardt M; Kaufhold A; Ito M; Lee M; Sasse C; Maher RM; Zeiher B; Vehreschild MJGT;
    Lancet Infect Dis; 2016 Jul; 16(7):828-837. PubMed ID: 26969258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 'cephalosporin era' of triazole therapy: isavuconazole, a welcomed newcomer for the treatment of invasive fungal infections.
    Chitasombat MN; Kontoyiannis DP
    Expert Opin Pharmacother; 2015; 16(10):1543-58. PubMed ID: 26100603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of isavuconazole after posaconazole toxicity in leukaemia patients.
    DiPippo AJ; Rausch CR; Kontoyiannis DP
    Mycoses; 2019 Jan; 62(1):81-86. PubMed ID: 30230043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.
    Desai AV; Kovanda LL; Hope WW; Andes D; Mouton JW; Kowalski DL; Townsend RW; Mujais S; Bonate PL
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.
    Rybak JM; Marx KR; Nishimoto AT; Rogers PD
    Pharmacotherapy; 2015 Nov; 35(11):1037-51. PubMed ID: 26598096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of isavuconazole in the treatment of invasive fungal infections.
    Wilson DT; Dimondi VP; Johnson SW; Jones TM; Drew RH
    Ther Clin Risk Manag; 2016; 12():1197-206. PubMed ID: 27536124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.
    Miceli MH; Kauffman CA
    Clin Infect Dis; 2015 Nov; 61(10):1558-65. PubMed ID: 26179012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Context of instauration and evolution under isavuconazole, a 2-year prospective real-life study.
    Pieragostini R; Xhaard A; Sauvageon H; Madelaine I; Touratier S; Denis B
    Med Mycol; 2023 Apr; 61(4):. PubMed ID: 36963767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.
    Jenks JD; Salzer HJ; Prattes J; Krause R; Buchheidt D; Hoenigl M
    Drug Des Devel Ther; 2018; 12():1033-1044. PubMed ID: 29750016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity.
    Ledoux MP; Denis J; Nivoix Y; Herbrecht R
    J Mycol Med; 2018 Mar; 28(1):15-22. PubMed ID: 29551442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.
    Wu X; Clancy CJ; Rivosecchi RM; Zhao W; Shields RK; Marini RV; Venkataramanan R; Nguyen MH
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy.
    Furfaro E; Signori A; Di Grazia C; Dominietto A; Raiola AM; Aquino S; Ghiggi C; Ghiso A; Ungaro R; Angelucci E; Viscoli C; Mikulska M
    J Antimicrob Chemother; 2019 Aug; 74(8):2341-2346. PubMed ID: 31119272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.